Searched for
API CALL PRICING
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 27%, according to analystsWe are in a phase in the US-Israel-Iran war where statements are made, then retracted. And, in a matter of just 48 hours, they are made all...- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- Why are oil prices up today, and will Brent futures and US WTI crude prices continue to rise or decline again? Iran war, Strait of Hormuz disruption and falling oil stockpiles drive marketWhy are oil prices up today, and will Brent futures and US WTI crude prices continue to rise or decline again? Oil prices moved higher and ...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsHas a peace deal been agreed on by the US and Iran? Will the fragile ceasefire hold? No one can answer these questions with any certainty. ...
- Chinese AI models surge in 2026: Is JPMorgan data signaling a global shift away from US AI dominance?Chinese AI models are no longer just regional competitors. They are rapidly becoming a global artificial intelligence force. New JPMorgan d...
- Be stock-specific, look for bargains: Daljeet Kohli on Nifty at 24,000 and top sector picksMarket expert Daljeet Kohli advises investors to focus on quality stocks at discounted prices, rather than the Nifty's movement. He highlig...
- Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
- Gig workers' incentives cool; YC attendees resell AI creditsHappy Tuesday! Despite a shortage of delivery workers, payouts for gig riders have increased only slightly this summer. This and more in to...
- Margin pressures lurk below AI pricing playShift to usage-based AI pricing may boost large-scale IT despite short-term margin pressures, writes Shristi Achar.
- OpenAI unveils three audio models for real-time voice tasksOpenAI has unveiled three new audio models for developers. These models aim to make voice agents more interactive and capable of real-time ...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...
- Why is AMD stock soaring nearly 19% after blockbuster earnings, and are AMD shares signaling Wall Street’s biggest AI power shift yet as demand rewrites the chip playbook?AMD stock up nearly 19% today after blockbuster earnings beat. Something shifted in the semiconductor world on Wednesday, May 6, 2026. AMD ...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat we are witnessing in the market these days is similar to scenarios that have played out in the past. There have been many points in th...
- Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisitionSun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...
- Weight-loss drug craze for Ozempic, Mounjaro surges in India amid safety concernsIn India, appetite for weight-loss drugs is on the rise, with consumers increasingly turning to injectables such as Mounjaro and Ozempic fo...
- Claude Opus 4.7 hits 92% honesty rate— are we closer than ever to human-like AI with less hallucination? Here’s what Anthropic’s new AI model is capable ofAnthropic says its latest AI model, Claude Opus 4.7, reaches a 92% honesty rate. That is a strong data point. It signals a push toward more...
- Iran conflict: Pharma supply chains may take months to recoverExperts said supply chains disrupted by the conflict will take months to stabilise, and prices of active pharmaceutical ingredients (APIs)-...
- Narendra Solanki sees limited IT growth, bets on rural and pharma playsInvestors are becoming selective, focusing on earnings visibility and strong balance sheets. Opportunities are emerging in sectors like IT,...
- Zhipu accelerates pivot to domestic chips amid AI boom in ChinaChinese AI firm Zhipu AI is boosting its use of local chips amid soaring computing needs. The company reported strong revenue growth for 20...
Load More
